Business Context and Reporting Period
This Form 8-K filing by Bally's Corporation (BALY) reports a material definitive agreement entered into on September 4, 2026, and publicly announced on September 14, 2026. The filing concerns a new financing facility for Bally's New York Operating Company, LLC, an indirect wholly-owned subsidiary.
Key Financial Metrics and Debt Structure
The filing details a new senior secured term loan facility with the following terms:
- Total Commitments: $560 million aggregate principal amount.
- Closing Date Term Loans: $400 million.
- Delayed Draw Term Loans: $160 million.
- Interest Rate: Term SOFR (subject to a floor) plus 8.50% per annum.
- Maturity: 18 months after initial funding.
- Collateral: Secured by substantially all assets of the Bally's New York Loan Parties.
- Use of Proceeds: Funding pre-construction costs for the Bally's Bronx project and general corporate purposes.
The filing does not provide current revenue, profit, cash flow, or margin data, as this is a transactional report rather than a periodic financial statement.
Material Changes and Covenants
The entry into this Loan Agreement represents a significant increase in indebtedness for the Bally's New York Loan Parties. Key contractual restrictions include:
- Covenants: Limitations on incurring additional indebtedness, paying dividends, making restricted payments, selling assets, making investments, and granting liens.
- Project Covenants: Specific construction and development covenants related to the Bally's Bronx project.
- Prepayment: Mandatory prepayment upon certain asset sales, casualty events, or unpermitted debt issuances. Voluntary prepayment is permitted without penalty, except for a customary fee on full prepayment.
- Conditions Precedent: Initial funding is subject to regulatory approval and satisfaction of customary conditions.
Outlook, Risks, and Contingencies
Management's outlook is tied to the successful execution of the Bally's Bronx project, for which this financing is intended. The filing highlights several risks and contingencies:
- Regulatory Risk: Funding is contingent upon regulatory approval.
- Default Risk: The agreement includes customary events of default (payment defaults, covenant breaches, bankruptcy, change of control) that could trigger acceleration of repayment and termination of unfunded commitments.
- Liquidity Constraints: The covenants restrict the subsidiary's ability to generate cash for dividends or other restricted payments until the debt is managed or covenants are waived.
Investor Verification Checklist
- Verify the status of regulatory approvals required for the initial funding of the $400 million closing date term loan.
- Confirm the specific timeline for the Bally's Bronx project pre-construction phase to assess the drawdown schedule of the $160 million delayed draw facility.
- Review the full text of the Loan Agreement to understand the specific "customary exceptions" to the collateral and prepayment provisions.
- Monitor future filings for any covenant waivers or amendments related to the Bally's New York Loan Parties.